ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti Asthma Drugs Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-11R7187
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anti Asthma Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti Asthma Drugs Market Research Report 2025

Code: QYRE-Auto-11R7187
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Astrazeneca plc
F.Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals

Anti Asthma Drugs Market Size

The global market for Anti Asthma Drugs was valued at US$ 22930 million in the year 2024 and is projected to reach a revised size of US$ 28880 million by 2031, growing at a CAGR of 3.4% during the forecast period.

Anti Asthma Drugs Market

Anti Asthma Drugs Market

Asthma is a chronic lung disease characterized by hyper responsiveness of tracheobronchial smooth muscle to stimuli, resulting in narrowing and inflammation of air tubes, accompanied by increased secretion, swelling and build-up of tissue fluid. Symptoms include tight chest, wheezing, cough and may be limitation of activity due to difficulty in breathing.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti Asthma Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Asthma Drugs.
The Anti Asthma Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti Asthma Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti Asthma Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Anti Asthma Drugs Market Report

Report Metric Details
Report Name Anti Asthma Drugs Market
Accounted market size in year US$ 22930 million
Forecasted market size in 2031 US$ 28880 million
CAGR 3.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Clinics
  • Hospitals
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline, Merck & Co, AstraZeneca, F. Hoffmann-La Roche, Teva Pharmaceutical, Novartis International, Boehringer Ingelheim, Sunovion Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anti Asthma Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anti Asthma Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Anti Asthma Drugs Market growing?

Ans: The Anti Asthma Drugs Market witnessing a CAGR of 3.4% during the forecast period 2025-2031.

What is the Anti Asthma Drugs Market size in 2031?

Ans: The Anti Asthma Drugs Market size in 2031 will be US$ 28880 million.

Who are the main players in the Anti Asthma Drugs Market report?

Ans: The main players in the Anti Asthma Drugs Market are GlaxoSmithKline, Merck & Co, AstraZeneca, F. Hoffmann-La Roche, Teva Pharmaceutical, Novartis International, Boehringer Ingelheim, Sunovion Pharmaceuticals

What are the Application segmentation covered in the Anti Asthma Drugs Market report?

Ans: The Applications covered in the Anti Asthma Drugs Market report are Clinics, Hospitals, Other

What are the Type segmentation covered in the Anti Asthma Drugs Market report?

Ans: The Types covered in the Anti Asthma Drugs Market report are Bronchodilators, Leukotriene Antagonists, Mast Cell Stabilizers, Corticosteroids, Monoclonal Antibody

Recommended Reports

Asthma & Respiratory

Allergy & Immune

General Pharmaceuticals

1 Anti Asthma Drugs Market Overview
1.1 Product Definition
1.2 Anti Asthma Drugs by Type
1.2.1 Global Anti Asthma Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Bronchodilators
1.2.3 Leukotriene Antagonists
1.2.4 Mast Cell Stabilizers
1.2.5 Corticosteroids
1.2.6 Monoclonal Antibody
1.3 Anti Asthma Drugs by Application
1.3.1 Global Anti Asthma Drugs Market Value by Application (2024 VS 2031)
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Other
1.4 Global Anti Asthma Drugs Market Size Estimates and Forecasts
1.4.1 Global Anti Asthma Drugs Revenue 2020-2031
1.4.2 Global Anti Asthma Drugs Sales 2020-2031
1.4.3 Global Anti Asthma Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Anti Asthma Drugs Market Competition by Manufacturers
2.1 Global Anti Asthma Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Anti Asthma Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Anti Asthma Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Anti Asthma Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anti Asthma Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anti Asthma Drugs, Product Type & Application
2.7 Global Key Manufacturers of Anti Asthma Drugs, Date of Enter into This Industry
2.8 Global Anti Asthma Drugs Market Competitive Situation and Trends
2.8.1 Global Anti Asthma Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Anti Asthma Drugs Players Market Share by Revenue
2.8.3 Global Anti Asthma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Anti Asthma Drugs Market Scenario by Region
3.1 Global Anti Asthma Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Anti Asthma Drugs Sales by Region: 2020-2031
3.2.1 Global Anti Asthma Drugs Sales by Region: 2020-2025
3.2.2 Global Anti Asthma Drugs Sales by Region: 2026-2031
3.3 Global Anti Asthma Drugs Revenue by Region: 2020-2031
3.3.1 Global Anti Asthma Drugs Revenue by Region: 2020-2025
3.3.2 Global Anti Asthma Drugs Revenue by Region: 2026-2031
3.4 North America Anti Asthma Drugs Market Facts & Figures by Country
3.4.1 North America Anti Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Anti Asthma Drugs Sales by Country (2020-2031)
3.4.3 North America Anti Asthma Drugs Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anti Asthma Drugs Market Facts & Figures by Country
3.5.1 Europe Anti Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Anti Asthma Drugs Sales by Country (2020-2031)
3.5.3 Europe Anti Asthma Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anti Asthma Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Anti Asthma Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Anti Asthma Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Anti Asthma Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anti Asthma Drugs Market Facts & Figures by Country
3.7.1 Latin America Anti Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Anti Asthma Drugs Sales by Country (2020-2031)
3.7.3 Latin America Anti Asthma Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anti Asthma Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anti Asthma Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Anti Asthma Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Anti Asthma Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anti Asthma Drugs Sales by Type (2020-2031)
4.1.1 Global Anti Asthma Drugs Sales by Type (2020-2025)
4.1.2 Global Anti Asthma Drugs Sales by Type (2026-2031)
4.1.3 Global Anti Asthma Drugs Sales Market Share by Type (2020-2031)
4.2 Global Anti Asthma Drugs Revenue by Type (2020-2031)
4.2.1 Global Anti Asthma Drugs Revenue by Type (2020-2025)
4.2.2 Global Anti Asthma Drugs Revenue by Type (2026-2031)
4.2.3 Global Anti Asthma Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Anti Asthma Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Anti Asthma Drugs Sales by Application (2020-2031)
5.1.1 Global Anti Asthma Drugs Sales by Application (2020-2025)
5.1.2 Global Anti Asthma Drugs Sales by Application (2026-2031)
5.1.3 Global Anti Asthma Drugs Sales Market Share by Application (2020-2031)
5.2 Global Anti Asthma Drugs Revenue by Application (2020-2031)
5.2.1 Global Anti Asthma Drugs Revenue by Application (2020-2025)
5.2.2 Global Anti Asthma Drugs Revenue by Application (2026-2031)
5.2.3 Global Anti Asthma Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Anti Asthma Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline
6.1.1 GlaxoSmithKline Company Information
6.1.2 GlaxoSmithKline Description and Business Overview
6.1.3 GlaxoSmithKline Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Anti Asthma Drugs Product Portfolio
6.1.5 GlaxoSmithKline Recent Developments/Updates
6.2 Merck & Co
6.2.1 Merck & Co Company Information
6.2.2 Merck & Co Description and Business Overview
6.2.3 Merck & Co Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Merck & Co Anti Asthma Drugs Product Portfolio
6.2.5 Merck & Co Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Anti Asthma Drugs Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Company Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 F. Hoffmann-La Roche Anti Asthma Drugs Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Company Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Teva Pharmaceutical Anti Asthma Drugs Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Novartis International
6.6.1 Novartis International Company Information
6.6.2 Novartis International Description and Business Overview
6.6.3 Novartis International Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis International Anti Asthma Drugs Product Portfolio
6.6.5 Novartis International Recent Developments/Updates
6.7 Boehringer Ingelheim
6.7.1 Boehringer Ingelheim Company Information
6.7.2 Boehringer Ingelheim Description and Business Overview
6.7.3 Boehringer Ingelheim Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Boehringer Ingelheim Anti Asthma Drugs Product Portfolio
6.7.5 Boehringer Ingelheim Recent Developments/Updates
6.8 Sunovion Pharmaceuticals
6.8.1 Sunovion Pharmaceuticals Company Information
6.8.2 Sunovion Pharmaceuticals Description and Business Overview
6.8.3 Sunovion Pharmaceuticals Anti Asthma Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sunovion Pharmaceuticals Anti Asthma Drugs Product Portfolio
6.8.5 Sunovion Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anti Asthma Drugs Industry Chain Analysis
7.2 Anti Asthma Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anti Asthma Drugs Production Mode & Process Analysis
7.4 Anti Asthma Drugs Sales and Marketing
7.4.1 Anti Asthma Drugs Sales Channels
7.4.2 Anti Asthma Drugs Distributors
7.5 Anti Asthma Drugs Customer Analysis
8 Anti Asthma Drugs Market Dynamics
8.1 Anti Asthma Drugs Industry Trends
8.2 Anti Asthma Drugs Market Drivers
8.3 Anti Asthma Drugs Market Challenges
8.4 Anti Asthma Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
GlaxoSmithKline PLC
Merck
Astrazeneca plc
F.Hoffmann-La Roche
Teva Pharmaceutical
Novartis International
Boehringer Ingelheim
Sunovion Pharmaceuticals
List of Tables
 Table 1. Global Anti Asthma Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Anti Asthma Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Anti Asthma Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Anti Asthma Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Anti Asthma Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Anti Asthma Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Anti Asthma Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Anti Asthma Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Anti Asthma Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Anti Asthma Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Anti Asthma Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Anti Asthma Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Anti Asthma Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Asthma Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Anti Asthma Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Anti Asthma Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Anti Asthma Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Anti Asthma Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Anti Asthma Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Anti Asthma Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Anti Asthma Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Anti Asthma Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Anti Asthma Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Anti Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Anti Asthma Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Anti Asthma Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Anti Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Anti Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Anti Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Anti Asthma Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Anti Asthma Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Anti Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Anti Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Anti Asthma Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Anti Asthma Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Anti Asthma Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Anti Asthma Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Anti Asthma Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Anti Asthma Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Anti Asthma Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Anti Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Anti Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Anti Asthma Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Anti Asthma Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Anti Asthma Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Anti Asthma Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Anti Asthma Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Anti Asthma Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Anti Asthma Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Anti Asthma Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Anti Asthma Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Anti Asthma Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Anti Asthma Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Anti Asthma Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Anti Asthma Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Anti Asthma Drugs Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Anti Asthma Drugs Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Anti Asthma Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Anti Asthma Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Anti Asthma Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Anti Asthma Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Anti Asthma Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Anti Asthma Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Anti Asthma Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Anti Asthma Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Anti Asthma Drugs Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Anti Asthma Drugs Price (USD/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Company Information
 Table 71. GlaxoSmithKline Description and Business Overview
 Table 72. GlaxoSmithKline Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Anti Asthma Drugs Product
 Table 74. GlaxoSmithKline Recent Developments/Updates
 Table 75. Merck & Co Company Information
 Table 76. Merck & Co Description and Business Overview
 Table 77. Merck & Co Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Merck & Co Anti Asthma Drugs Product
 Table 79. Merck & Co Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Anti Asthma Drugs Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. F. Hoffmann-La Roche Company Information
 Table 86. F. Hoffmann-La Roche Description and Business Overview
 Table 87. F. Hoffmann-La Roche Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. F. Hoffmann-La Roche Anti Asthma Drugs Product
 Table 89. F. Hoffmann-La Roche Recent Developments/Updates
 Table 90. Teva Pharmaceutical Company Information
 Table 91. Teva Pharmaceutical Description and Business Overview
 Table 92. Teva Pharmaceutical Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Teva Pharmaceutical Anti Asthma Drugs Product
 Table 94. Teva Pharmaceutical Recent Developments/Updates
 Table 95. Novartis International Company Information
 Table 96. Novartis International Description and Business Overview
 Table 97. Novartis International Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Novartis International Anti Asthma Drugs Product
 Table 99. Novartis International Recent Developments/Updates
 Table 100. Boehringer Ingelheim Company Information
 Table 101. Boehringer Ingelheim Description and Business Overview
 Table 102. Boehringer Ingelheim Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Boehringer Ingelheim Anti Asthma Drugs Product
 Table 104. Boehringer Ingelheim Recent Developments/Updates
 Table 105. Sunovion Pharmaceuticals Company Information
 Table 106. Sunovion Pharmaceuticals Description and Business Overview
 Table 107. Sunovion Pharmaceuticals Anti Asthma Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Sunovion Pharmaceuticals Anti Asthma Drugs Product
 Table 109. Sunovion Pharmaceuticals Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Anti Asthma Drugs Distributors List
 Table 113. Anti Asthma Drugs Customers List
 Table 114. Anti Asthma Drugs Market Trends
 Table 115. Anti Asthma Drugs Market Drivers
 Table 116. Anti Asthma Drugs Market Challenges
 Table 117. Anti Asthma Drugs Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Anti Asthma Drugs
 Figure 2. Global Anti Asthma Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti Asthma Drugs Market Share by Type: 2024 & 2031
 Figure 4. Bronchodilators Product Picture
 Figure 5. Leukotriene Antagonists Product Picture
 Figure 6. Mast Cell Stabilizers Product Picture
 Figure 7. Corticosteroids Product Picture
 Figure 8. Monoclonal Antibody Product Picture
 Figure 9. Global Anti Asthma Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Anti Asthma Drugs Market Share by Application: 2024 & 2031
 Figure 11. Clinics
 Figure 12. Hospitals
 Figure 13. Other
 Figure 14. Global Anti Asthma Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Anti Asthma Drugs Market Size (2020-2031) & (US$ Million)
 Figure 16. Global Anti Asthma Drugs Sales (2020-2031) & (K Units)
 Figure 17. Global Anti Asthma Drugs Average Price (USD/Unit) & (2020-2031)
 Figure 18. Anti Asthma Drugs Report Years Considered
 Figure 19. Anti Asthma Drugs Sales Share by Manufacturers in 2024
 Figure 20. Global Anti Asthma Drugs Revenue Share by Manufacturers in 2024
 Figure 21. Global 5 and 10 Largest Anti Asthma Drugs Players: Market Share by Revenue in Anti Asthma Drugs in 2024
 Figure 22. Anti Asthma Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 23. Global Anti Asthma Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 24. North America Anti Asthma Drugs Sales Market Share by Country (2020-2031)
 Figure 25. North America Anti Asthma Drugs Revenue Market Share by Country (2020-2031)
 Figure 26. U.S. Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Canada Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Europe Anti Asthma Drugs Sales Market Share by Country (2020-2031)
 Figure 29. Europe Anti Asthma Drugs Revenue Market Share by Country (2020-2031)
 Figure 30. Germany Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. France Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. U.K. Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Italy Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Russia Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Asia Pacific Anti Asthma Drugs Sales Market Share by Region (2020-2031)
 Figure 36. Asia Pacific Anti Asthma Drugs Revenue Market Share by Region (2020-2031)
 Figure 37. China Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Japan Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. South Korea Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. India Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Australia Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Taiwan Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Indonesia Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Thailand Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Malaysia Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Philippines Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Latin America Anti Asthma Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Latin America Anti Asthma Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Mexico Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Brazil Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Argentina Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Middle East and Africa Anti Asthma Drugs Sales Market Share by Country (2020-2031)
 Figure 53. Middle East and Africa Anti Asthma Drugs Revenue Market Share by Country (2020-2031)
 Figure 54. Turkey Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Saudi Arabia Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. U.A.E Anti Asthma Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. Global Sales Market Share of Anti Asthma Drugs by Type (2020-2031)
 Figure 58. Global Revenue Market Share of Anti Asthma Drugs by Type (2020-2031)
 Figure 59. Global Anti Asthma Drugs Price (USD/Unit) by Type (2020-2031)
 Figure 60. Global Sales Market Share of Anti Asthma Drugs by Application (2020-2031)
 Figure 61. Global Revenue Market Share of Anti Asthma Drugs by Application (2020-2031)
 Figure 62. Global Anti Asthma Drugs Price (USD/Unit) by Application (2020-2031)
 Figure 63. Anti Asthma Drugs Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

Asthma Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Nebulizers Inhalers and Respirators for Asthma Treatment Market Research Report 2024
Global Asthma Immunotherapies Market Research Report 2024
Global Asthma Treatment Market Insights Forecast to 2030
Global Asthma and COPD Devices Market Insights Forecast to 2030
Asthma and COPD Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Maintenance Inhaler Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Respiratory Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Chronic Obstructive Pulmonary Disease Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Respiratory Drug Market Research Report 2024
Quick acting Asthma Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
COPD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antiasthmatic Drug Market Research Report 2024
Global Anti Asthmatics and COPD Drugs Market Research Report 2024
Global Human Respiratory Disease Treatment Market Research Report 2025
Respiratory Inhaler Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Drugs for Asthma and COPD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Asthma Medication Market Research Report 2025
Global Asthma Nebulizer Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions